Predictive Factors of Febrile Neutropenia Induced by Anticancer Chemotherapy in the South of Tunisia

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|11|1|72-76

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.11, Iss.1, 2016-03, pp. : 72-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 283-284

Karger

Access to resources Recommend Favorite

MONITOR‐GCSF DLBCL subanalysis: Treatment patterns/outcomes with biosimilar filgrastim for chemotherapy‐induced/febrile neutropenia prophylaxis

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 241-246

John Wiley & Sons Inc

Access to resources Recommend Favorite

G-CSF in the Prevention of Febrile Neutropenia in Chemotherapy in Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 29, Iss. 4, 2006-03 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study

By Tan Hiangkiat   Tomic Karen   Hurley Dana   Daniel Gregory   Barron Rich   Malin Jen  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 79-86

Informa Healthcare

Access to resources Recommend Favorite

Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study

By Fiegl Michael   Steger Günther G.   Studnicka Michael   Eisterer Wolfgang   Jaeger Christine   Willenbacher Wolfgang  

Current Medical Research and Opinion, Vol. 29, Iss. 5, 2013-05 ,pp. : 505-515

Informa Healthcare

Access to resources Recommend Favorite